Načítá se...

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

BACKGROUND: Immunotherapy is an ideal treatment modality to specifically target the diffusely infiltrative tumor cells of malignant gliomas while sparing the normal brain parenchyma. However, progress in the development of these therapies for glioblastoma has been slow due to the lack of immunogenic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Everson, Richard G., Antonios, Joseph P., Lisiero, Dominique N., Soto, Horacio, Scharnweber, Rudi, Garrett, Matthew C., Yong, William H., Li, Ning, Li, Gang, Kruse, Carol A., Liau, Linda M., Prins, Robert M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767237/
https://ncbi.nlm.nih.gov/pubmed/26330563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov153
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!